2d
MedPage Today on MSNOnce-Yearly Lenacapavir PrEP a Safe, Promising Alternative to Twice-Yearly DosingA once-yearly intramuscular lenacapavir (Sunlenca) injection was safe and well-tolerated and had higher median levels of ...
Data from a very early-phase trial shows that the drug is safe and remains in the body for up to 56 weeks. From two ...
Gilead has reported results for a once-yearly intramuscular injection that show blood concentrations of lenacapavir exceeded ...
After Gilead Sciences' lenacapavir made waves with stellar clinical results as a twice-yearly HIV prevention candidate, the ...
An oncologist from Atrium Health outlines how saving time administering immunotherapy could have far-reaching benefits.
Celltrion has launched Steqeyma (ustekinumab-stba), its biosimilar of Stelara (ustekinumab), at list price at an 85% discount ...
The FDA approved a prefilled syringe format for Ani's purified Cortrophin Gel that should ease administration for MS patients ...
Subcutaneous administration of trastuzumab and pertuzumab significantly shortened the time patients with stage I ...
She started treatment with etanercept (Enbrel ®) 1 month previously. One day after a subcutaneous injection into the left thigh, she developed a mildly pruritic eruption on the right thigh ...
Rybelsus comes as a tablet that you swallow, while Ozempic is given as a subcutaneous injection. Both Rybelsus and Ozempic contain the active ingredient semaglutide. They belong to a class of ...
In fact, the once-a-year intramuscular injection of 5000 mg of lenacapavir showed a higher concentration of the drug remained in the body than two lower-dose subcutaneous injections six months apart.
Wegovy (semaglutide) is a brand-name subcutaneous injection (shot) prescribed for weight loss and to lower the risk of cardiovascular problems in some people. As with other drugs, Wegovy can cause ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results